Discover
GSK
GSK plc
51.16
3 x 51.15
5 x 51.16
bid
ask
-
1.00
1.93%
01:41 PM
timesize
| Ytd | 4.31% | |
| 1y | 35.65% |
51.10
day range
52.35
37.80
52 week range
61.70
| Open | 51.99 | Prev Close | 52.16 | Low | 51.10 | High | 52.35 | Mkt Cap | 102.50B |
| Vol | 1.74M | Avg Vol | 4.01M | EPS | 4.63 | P/E | 11.05 | Forward P/E | 10.31 |
| Beta | 0.36 | Short Ratio | 3.97 | Inst. Own | 18.68% | Dividend | 1.79 | Div Yield | 3.43 |
| Ex Div Date | 08-14 | Earning | 07-28 | 50-d Avg | 51.76 | 200-d Avg | 51.85 | 1yr Est | 58.08 |
| Income Statement | |||
| Total Revenue | 8.41B | ||
| Revenues (USD) | 11.21B | ||
| Cost of Revenue | 2.27B | ||
| Gross Profit | 6.14B | ||
| Operating Expenses | 5.66B | ||
| Research and Development Expense | 3.47B | ||
| Selling, General and Administrative Expense | 2.20B | ||
| Operating Income | 481.00M | ||
| Interest Expense | 182.00M | ||
| Income Tax Expense | -199.00M | ||
| Net Income | 435.00M | ||
| Net Income Common Stock | 435.00M | ||
| Net Income Common Stock (USD) | 580.00M | ||
| Consolidated Income | 553.00M | ||
| Net Income to Non-Controlling Interests | 118.00M | ||
| Earnings per Basic Share | 0.22 | ||
| Earnings per Basic Share (USD) | 0.29 | ||
| Earnings per Diluted Share | 0.21 | ||
| Dividends per Basic Common Share | 0.43 | ||
| Earning Before Interest & Taxes (EBIT) | 418.00M | ||
| Earning Before Interest & Taxes (USD) | 557.33M | ||
| Weighted Average Shares | 4.02B | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.11B | ||
| Cash and Equivalents (USD) | 4.14B | ||
| Investments | 956.00M | ||
| Investments Current | 1000.00K | ||
| Investments Non-Current | 955.00M | ||
| Trade and Non-Trade Receivables | 7.71B | ||
| Current Assets | 17.56B | ||
| Property, Plant & Equipment Net | 10.03B | ||
| Total Assets | 61.74B | ||
| Debt Current | 4.29B | ||
| Total Debt | 18.24B | ||
| Current Liabilities | 21.53B | ||
| Debt Non-Current | 13.95B | ||
| Total Liabilities | 44.56B | ||
| Accumulated Retained Earnings (Deficit) | 11.46B | ||
| Shareholders Equity | 17.65B | ||
| Shareholders Equity (USD) | 23.53B | ||
| Assets Non-Current | 44.18B | ||
| Total Debt (USD) | 24.32B | ||
| Goodwill and Intangible Assets | 24.18B | ||
| Inventory | 6.28B | ||
| Liabilities Non-Current | 23.03B | ||
| Trade and Non-Trade Payables | 14.34B | ||
| Tax Assets | 6.71B | ||
| Tax Liabilities | 827.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.29B | ||
| Net Cash Flow from Financing | -2.15B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -248.00M | ||
| Capital Expenditure | -325.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -643.00M | ||
| Issuance (Purchase) of Equity Shares | -307.00M | ||
| Issuance (Repayment) of Debt Securities | -685.00M | ||
| Payment of Dividends & Other Cash Distributions | -727.00M | ||
| Net Cash Flow from Investing | -789.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 178.00M | ||
| Net Cash Flow from Operations | 2.69B | ||
| Effect of Exchange Rate Changes on Cash | -7.00M | ||